| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.093 | 0.4 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |